metformin hydrochloride 500 MG / pioglitazone 15 MG Oral Tablet
metformin hydrochloride
RxCUI: 861783
What the CMS Formulary Data Shows for metformin hydrochloride 500 MG / pioglitazone 15 MG Oral Tablet
Per the CMS 2026 Part D formulary file, metformin hydrochloride 500 MG / pioglitazone 15 MG Oral Tablet (RxNorm concept RXCUI 861783, generic name metformin hydrochloride) appears on 278 distinct formulary files spanning 4,628 Medicare Part D plan offerings - 91.3% of enrollable Part D products, near-universal placement. Tier placement ranges from Tier 1 to Tier 6, with a cross-plan average of Tier 2.6.
Real-world access to metformin hydrochloride 500 MG / pioglitazone 15 MG Oral Tablet depends on utilization management as much as tier placement: 0% of covering formularies require prior authorization. 0% require step therapy. 84.9% apply quantity limits.
Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 5,918,026 Part D beneficiaries filled metformin hydrochloride 500 MG / pioglitazone 15 MG Oral Tablet in 2023, with total plan-and-beneficiary spending of $247,531,906 and an average per-beneficiary annual cost of $41.83. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry metformin hydrochloride 500 MG / pioglitazone 15 MG Oral Tablet today.
Coverage Details
- Formularies covering
- 278
- Plans covering
- 4,628
- Coverage rate
- 91.3%
- Tier range
- Tier 1 – Tier 6
- Average tier
- Tier 3, Preferred Brand
Restrictions
- Prior authorization required
- 0% of formularies
- Step therapy required
- 0% of formularies
- Quantity limits
- 84.9% of formularies
2023 Medicare Spending
- Beneficiaries
- 5,918,026
- Total spending
- $247,531,906
- Avg per beneficiary
- $41.83
Tier Distribution Across Plans
Medicare Advantage Plans (MA-PD) Covering metformin hydrochloride 500 MG / pioglitazone 15 MG Oral Tablet
100 Medicare Advantage plans with Part D drug coverage include this drug.
Frequently Asked Questions
Is metformin hydrochloride 500 MG / pioglitazone 15 MG Oral Tablet covered by Medicare Part D?
Yes, metformin hydrochloride 500 MG / pioglitazone 15 MG Oral Tablet is covered by 4,628 Medicare Part D plans (91.3% of all Part D formularies).
What tier is metformin hydrochloride 500 MG / pioglitazone 15 MG Oral Tablet on Medicare Part D plans?
metformin hydrochloride 500 MG / pioglitazone 15 MG Oral Tablet averages Tier 2.6 across Part D plans, ranging from Tier 1 to Tier 6.
Does metformin hydrochloride 500 MG / pioglitazone 15 MG Oral Tablet require prior authorization?
0% of Part D formularies require prior authorization for metformin hydrochloride 500 MG / pioglitazone 15 MG Oral Tablet. Step therapy: 0%. Quantity limits: 84.9%.
How much does Medicare spend on metformin hydrochloride 500 MG / pioglitazone 15 MG Oral Tablet?
In 2023, total Medicare Part D spending on metformin hydrochloride 500 MG / pioglitazone 15 MG Oral Tablet was $247,531,906, covering 5,918,026 beneficiaries. The average spend per beneficiary was $41.83.
Read our methodology - how this data is sourced, computed, and verified.